Imagine that the next time your doctor orders a round of tests, in addition to cholesterol and vitamin D, she also orders a genome sequence. It sounds like science fiction, but the day might come sooner than you think.
Precision medicine—in which each patient’s prevention and treatment decisions are tailored for them—has been a buzzword in the health care industry recently. President Barack Obama launched his Precision Medicine Initiative, and other countries have similar projects underway.
With concerns about the cost of health care, though, can we afford precision medicine?
In certain instances, precision medicine can actually save money. For example, if patients can be screened for drug hypersensitivity before being prescribed certain drugs, they won’t have to be treated later, which is better for patients and cuts down on costs. A similar approach works for choosing treatments.
“When you use a therapy to target only the individuals who will benefit, you avoid wasting drugs or other resources on people who you know won’t get any benefit, and who might actually be harmed,” said David Threadgill, Ph.D., professor and holder of the Tom and Jean McMullin Chair of Genetics at the Texas A&M Health Science Center College of Medicine and director of the Texas A&M Institute for Genome Sciences and Society.
Of course, it’s not quite that simple. “Whether the economics works out in favor of precision medicine depends on two things: the difficulty and the cost of finding the best candidates who will benefit from specific, tailored treatments,” said Robert L. Ohsfeldt, Ph.D., health economist and professor in the Department of Health Policy & Management at the Texas A&M School of Public Health. “You have to know a lot about the disease process and how individual characteristics—genetics and environmental factors like diet or exposure to toxins—mediate the treatment response.”
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicineon January 17, 2022 at 5:00 am
Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that Peter Krein has ...
- Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy With Imperial College London Research Collaborationon January 17, 2022 at 3:37 am
STALLERGENES GREER STRENGTHENS PRECISION MEDICINE APPROACH IN ALLERGEN IMMUNOTHERAPY WITH IMPERIAL COLLEGE LONDON RESEARCH COLLABORATION ...
- Antech introduces veterinary medicine's most advanced parasite screening teston January 17, 2022 at 3:30 am
Representing two decades of foundational research and a new standard of care in veterinary medicine, Antech Diagnostics announced today veterinary medicine's most sensitive test for intestinal ...
- ASPIRE funds 3 VRIs in precision medicine, food security and sustainable energyon January 14, 2022 at 12:50 am
The VRIs will bring together internationally-recognised talent from leading universities.. ASPIRE funds 3 VRIs in precision medicine, food security and sustainable energy. ASPIRE, food security, ...
- One Health Company Collaborates with IDEXX to Expand Access to FidoCure® Precision Medicine Platformon January 13, 2022 at 9:06 am
One Health Company, a bio company bridging the gap between canine and human cancer precision medicine, today announced a collaboration with IDEXX Laboratories, Inc., a global leader in pet healthcare ...
- UAE: Dh200 million fund to enhance biotechnology for precision medicine, food security, sustainable energy productionon January 13, 2022 at 6:43 am
The cumulative Dh200 million funding across five years, marks a significant investment in research and innovation development, and it highlights the commitment of the Abu Dhabi government to build ...
- Immunotherapy, Precision Medicine are Coming on Strong in Oncologyon January 12, 2022 at 7:58 am
But the future of value-based care in oncology is uncertain with no certain successor to the Oncology Care Model in sight.
- Advancements in Metabolomics and Subsequent Progress in Precision Medicine to Fuel Revenue Growth of the Metabolomics Market: Reports and Dataon January 12, 2022 at 4:00 am
Reports and Data has recently published its latest report titled "Metabolomics Market By Product & Services (Metabolomics Separation ...
- Crain Communications acquires precision-medicine media brandon January 11, 2022 at 5:42 am
Detroit-based Crain Communications Inc., the parent company of Plastics News, has acquired Kneed Media, parent company of the Journal of Precision Medicine and its accompanying series, the Precision ...
- Big Data, Surveillance Capitalism, and Precision Medicine: Challenges for Privacyon January 10, 2022 at 9:59 am
Surveillance capitalism companies, such as Google and Facebook, have substantially increased the amount of information collected, analyzed, and monetized, including health information increasingly ...
via Bing News